Comparative efficacy of teclistamab versus real-world physician's choice of therapy in the prospective LocoMMotion study in patients with triple-class exposed relapsed/refractory multiple myeloma
Clinical Lymphoma Myeloma and Leukemia（2022）
关键词
relapsed/refractory multiple myeloma,multiple myeloma,prospective locommotion study,teclistamab,real-world,triple-class
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要